Imperial College London
- Country
- 🇧🇪Belgium
- Ownership
- Private
- Established
- 1907-07-08
- Employees
- 5K
- Market Cap
- -
- Website
- http://www.imperial.ac.uk
Mechanisms of Severe Acute Influenza Consortium (MOSAIC)
- Conditions
- Influenza
- First Posted Date
- 2009-08-25
- Last Posted Date
- 2019-07-08
- Lead Sponsor
- Imperial College London
- Target Recruit Count
- 131
- Registration Number
- NCT00965354
- Locations
- 🇬🇧
Chelsea and Westminster Hospital NHS Foundation Trust, London, United Kingdom
🇬🇧Liverpool Women's NHS Foundation Trust, Liverpool, United Kingdom
🇬🇧Aintree Hospitals NHS Trust, Liverpool, United Kingdom
Chemotherapy or Letrozole Before Surgery in Treating Postmenopausal Women With Breast Cancer That Can Be Removed By Surgery
- Conditions
- Breast Cancer
- Interventions
- First Posted Date
- 2009-08-21
- Last Posted Date
- 2013-08-12
- Lead Sponsor
- Imperial College London
- Target Recruit Count
- 756
- Registration Number
- NCT00963729
- Locations
- 🇬🇧
St. Mary's Hospital, London, England, United Kingdom
🇰🇷Asan Medical Center - University of Ulsan College of Medicine, Seoul, Korea, Republic of
🇬🇧West Middlesex University Hospital, Isleworth, England, United Kingdom
To Assess Neuroinflammation and Neurocognitive Function in Patients With Acute Hepatitis C and Chronic HIV Co-Infection
- Conditions
- HIVHIV InfectionsAcute Hepatitis C
- Interventions
- Other: PET scan
- First Posted Date
- 2009-08-14
- Last Posted Date
- 2019-10-22
- Lead Sponsor
- Imperial College London
- Target Recruit Count
- 81
- Registration Number
- NCT00959166
- Locations
- 🇬🇧
St Mary's Hospital, London, United Kingdom
Guanfacine for the Treatment of Spatial Neglect and Impaired Vigilance
- First Posted Date
- 2009-08-10
- Last Posted Date
- 2020-01-21
- Lead Sponsor
- Imperial College London
- Target Recruit Count
- 13
- Registration Number
- NCT00955253
- Locations
- 🇬🇧
Imperial College Healthcare NHS Trust, London, United Kingdom
Spondylitis Trial of Apremilast for Better Rheumatic Therapy
- Conditions
- Ankylosing Spondylitis
- Interventions
- Drug: Placebo (sugar pill)
- First Posted Date
- 2009-07-23
- Last Posted Date
- 2019-12-06
- Lead Sponsor
- Imperial College London
- Target Recruit Count
- 38
- Registration Number
- NCT00944658
- Locations
- 🇬🇧
The Kennedy Institute Clinical Trials Unit, 4 West, Charing Cross Hospital, London, United Kingdom
Neuroprotective Effects of Hypothermia Combined With Inhaled Xenon Following Perinatal Asphyxia
- Conditions
- Hypoxic Ischaemic Encephalopathy
- Interventions
- Other: Xenon gas
- First Posted Date
- 2009-07-08
- Last Posted Date
- 2022-04-21
- Lead Sponsor
- Imperial College London
- Target Recruit Count
- 92
- Registration Number
- NCT00934700
- Locations
- 🇬🇧
Imperial College Academic Healthcare Trust, London, United Kingdom
Effect of Oligofructose on Appetite in Overweight Subjects
- Conditions
- Appetite RegulationObesity
- Interventions
- Dietary Supplement: OligofructoseDietary Supplement: Placebo
- First Posted Date
- 2009-06-03
- Last Posted Date
- 2021-01-14
- Lead Sponsor
- Imperial College London
- Target Recruit Count
- 28
- Registration Number
- NCT00912197
- Locations
- 🇬🇧
Imperial College London, Hammersmith Hospital, London, United Kingdom
Discard:Characterisation of Colonic Polyps in Vivo
- Conditions
- Colorectal Polyps
- First Posted Date
- 2009-04-28
- Last Posted Date
- 2022-08-05
- Lead Sponsor
- Imperial College London
- Target Recruit Count
- 130
- Registration Number
- NCT00888771
- Locations
- 🇬🇧
Wolfson Unit for Endoscopy, St Mark's Hospital, Harrow, Moddlesex, United Kingdom
Effect of Preoperative Chemoradiotherapy on Exercise Capacity as Measured by Cardiopulmonary Exercise Testing
- Conditions
- Colorectal Cancer
- Interventions
- Other: Cardiopulmonary exercise testing
- First Posted Date
- 2009-02-02
- Last Posted Date
- 2016-02-17
- Lead Sponsor
- Imperial College London
- Target Recruit Count
- 40
- Registration Number
- NCT00833508
- Locations
- 🇬🇧
Imperial NHS Trust, St Mary's Hospital, Praed Street, London, United Kingdom
The HAM Infliximab Study
- First Posted Date
- 2009-01-15
- Last Posted Date
- 2013-04-15
- Lead Sponsor
- Imperial College London
- Target Recruit Count
- 3
- Registration Number
- NCT00823641
- Locations
- 🇬🇧
Imperial College Healthcare NHS Trust, London, United Kingdom